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MxR could become a useful tool in planning TAVR measurements due
to true 3D perception by an operator.

compared between these groups. The Kruskal-Wallis test was used to
evaluate statistical signiﬁcance.

CATEGORIES STRUCTURAL: Valvular Disease: Aortic

RESULTS The mean duration of TEE procedures, the number of images, and the number of 3D clips were all signiﬁcantly higher in the
interventional imaging TEER group compared with the noninterventional groups (P < 0.0001) (Table 1). The duration and number of
images were also signiﬁcantly higher among valvular compared with
nonvalvular SOC TEE groups (P < 0.0002) as well as number of 3D
clips (P < 0.0012).

TCT-377
Automated Robotic TCD for RLS Detection in the Evaluation of
Patients with Cryptogenic Stroke
Ruchir Shah
CHI Memorial Hospital, Chattanooga, Tennessee, USA
BACKGROUND Ischemic stroke is a heterogeneous condition and requires a detailed workup to properly identify the underlying mechanisms to better inform treatment and secondary prevention. One such
mechanism, the presence of a patent foramen oval (PFO), has long
been associated with an increased risk of recurrent stroke. Recent
randomized controlled trials have demonstrated the beneﬁts of
percutaneous PFO closure over medical therapy alone for secondary
prevention of recurrent ischemic stroke in a selected population. One
critical element of patient selection through established clinical algorithms is the presence and size of the PFO. Several guideline recommendations highlight the superior sensitivity of transcranial
Doppler (TCD) for the identiﬁcation of right-to-left shunt (RLS)
compared with TTE; however, user dependence and inaccessibility
have limited TCD use within the cryptogenic stroke workup. The
purpose of this study is to evaluate the role of automated TCD (aTCD
[NovaGuide, NovaSignal Corp]) in cryptogenic stroke against transthoracic echocardiography (TTE) and transesophageal echocardiography (TEE) for RLS diagnosis.
METHODS Cryptogenic stroke patients admitted to our regional
medical center were scanned by a non-TCD expert using a robotic, 5degree-of-freedom aTCD as part of the cryptogenic stroke workﬂow
for the assessment of RLS using the Spencer logarithmic scale (SLS)
grade for shunt quantiﬁcation. Standard of care TTE with bubble was
performed, and if the aTCD was positive, TEE was performed for
further risk stratiﬁcation.
RESULTS A total of 70 (44% female) patients with an average age of
57.8 years were scanned by aTCD. Of these scans, 67% (n ¼ 47) were
identiﬁed by aTCD for RLS, and 47% (n ¼ 33) had a positive shunt with
SLS grade of 3 or greater.
CONCLUSION The accurate identiﬁcation of PFO is a critical element
in the workup of patients with cryptogenic stroke. We successfully
integrated aTCD into the clinical workﬂow, and the identiﬁcation rate
of RLS using aTCD compared well against the recent prospective study
(NCT04604015), which was compared with TTE bubble. The incorporation of aTCD into the cryptogenic stroke workup can provide
highly sensitive detection and quantiﬁcation of RLS.
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BACKGROUND Intraprocedural structural heart imaging is more
challenging and has unique differences from standard of care (SOC)
imaging. However, the variations in time and complexity of different
types of SOC transesophageal echocardiographs (TEEs) versus interventional TEEs is not well studied. In this study, we aim to compare
the complexity of SOC nonvalvular indication TEE with SOC valvular
TEE studies and interventional TEEs performed in the guidance of
transcatheter edge-to-edge repair (TEER) MitraClip (Abbott Vascular)
procedures.
METHODS A retrospective case-control analysis was performed on
200 patients who underwent TEE in the Henry Ford Health System.
One hundred cases of interventional TEE-guided TEER were
compared with 73 nonvalvular (endocarditis and stroke evaluation)
SOC TEEs and 27 valvular (preprocedural mitral, aortic, and tricuspid
valve evaluations) SOC TEEs. Complexity was quantiﬁed by the total
procedure duration, the total number of images, and the number of 3dimensional (3D) clips captured. The mean, median, and SD were
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<0.0001

images

Number of 3D

SD

27.63

22.68

83.91

Median

67

89

193.5

Mean
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4
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32

<0.0001

clips

CONCLUSION Interventional TEE was more complicated and timeconsuming compared with SOC TEE performed for both nonvalvular
and valvular indications. The latter was also more complex than SOC
nonvalvular TEE. This is the ﬁrst study of its kind demonstrating
objective differences between interventional and 2 SOC TEE groups.
These results emphasize the need of dedicated training for intraprocedural imaging as well as restructuring of reimbursement codes.
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BACKGROUND The majority of patients undergoing left atrial
appendage occlusion (LAAO) are at increased risk of bleeding. The
optimal postprocedural antithrombotic regimen to prevent both
ischemic and hemorrhagic complications remains undetermined. We
aimed to evaluate the long-term efﬁcacy and safety of single antiplatelet therapy (SAPT) after LAAO.
METHODS All Danish LAAO patients treated between March 2010 and
December 2021 were identiﬁed through the nationwide Danish health
registries. Discharge medication and clinical outcomes were obtained
from the Danish National Prescription Registry and the Danish National Patient Registry, containing prospectively collected patientlevel data on all reimbursed prescriptions and all hospitalizations
across Denmark. The outcomes of interest were ischemic stroke, major
bleeding, and all-cause mortality.
RESULTS A total of 1,462 patients underwent LAAO during the study
period with 799 (55%) discharged on SAPT, 469 (32%) on dual antiplatelet therapy (DAPT), and 94 (6%) on oral anticoagulation/SAPT
combination therapy. The median follow-up was 2.6 years (IQR: 1.24.5). Comparing patients discharged on SAPT with the DAPT population, the mean CHA2DS2-VASc was 3.0 þ 1.4A versus 3.2 þ 1.5 (P ¼
0.058), and the HAS-BLED scores were 1.8 þ 0.9 versus 1.6 þ 0.8 (P <
0.001). Prior intracranial hemorrhage was more frequent in the SAPT
population (175 [21.9%] vs 64 [13.6%]; P < 0.001). No difference in the
crude annualized stroke rate (SAPT: 2.1% [95% CI: 1.5-2.7] vs DAPT:
2.1% [95% CI: 1.8-2.7]), intracranial hemorrhage (SAPT: 0.7% [95% CI:
0.4-1.1] vs DAPT: 0.6% [95% CI: 0.4-0.9]), extracranial major bleeding
(SAPT: 2.6% [95% CI: 2.0-3.5] vs DAPT: 2.5% [95% CI: 2.1-3.1]), or all-
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